Search Results 531-540 of 19234 for Hemoglobin

1. Cisplatin and Etoposide or Temozolomide and Capecitabine in Treating Patients With Neuroendocrine Carcinoma of the Gastrointestinal Tract or Pancreas That Is Metastatic or Cannot Be Removed by Surgery - Mayo Clinic

   Hemoglobin ≥ 9 g/dL. Hemoglobin: ______ Date: ______. Platelets ≥ 100,000/mm^3. Platelets: ______ Date: ______. Total bilirubin ≤ institutional upper ...

2. Artificial sweeteners: Any effect on blood sugar? - Mayo Clinic

   Sucralose (Splenda). Artificial sweeteners are many times sweeter than sugar. So it takes only a small amount of an artificial sweetener to sweeten foods.

3. A Study of Tumor DNA Mutations in the Peripheral Blood from Patients who have Cholangiocarcinoma - Mayo Clinic

   Patient with significant anemia (Hemoglobin <7g/dL). Participating Mayo Clinic locations. Study statuses change often. Please contact the study team for the ...

4. ECG Patch for Monitoring Potassium Levels in Patients with Cardiac and Renal Disease - Mayo Clinic

   Patients who have a hemoglobin of < 8mg/dl in the last 30 days. Participating Mayo Clinic locations. Study statuses change often. Please contact the study ...

5. Ixabepilone and Temsirolimus in Treating Patients with Solid Tumors that are Metastatic or Cannot ce Removed by Surgery - Mayo Clinic

   Hemoglobin ≥ 9.0 g/dL; Platelets ≥ 100,000/mcL; Total bilirubin < 1.5 mg/dL; Serum glutamate pyruvate transaminase (SGPT) (alanine aminotransferase [ALT]) or ...

6. Study to Assess Painful Diabetic Peripheral Neuropathy After High-frequency Spinal Cord Stimulation - Mayo Clinic

   Hemoglobin A1c > 8%. Stable opioid regimen with oral morphine equivalent ≥ 100 mg/day. Alternative principle cause for peripheral neuropathy or lower ...

7. Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations - Mayo Clinic

   Hemoglobin ≥ 9.0 g/dL; Total bilirubin ≤ 1.5 x institutional upper limit of normal (ULN); Aspartate transaminase (AST); alanine aminotransferase (ALT) ...

8. MicroOrganoSphere Drug Screen Pilot Trial in Colorectal Cancer (CRC) - Mayo Clinic

   Hemoglobin ≥ 8 g/dL (transfusions are permitted to achieve baseline hemoglobin level);. ALT/AST (alanine aminotransferase (ALT) / aspartate aminotransferase ...

9. Spine Procedures Clinical Trials - Mayo Clinic Research

   ... hemoglobin monitoring compared to invasive blood draw, and to evaluate cost effectiveness of noninvasive monitoring in comparison to invasive blood draws.

10. HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide - Mayo Clinic

    corrected for hemoglobin > 50% and forced expiratory volume in first second (FEV1) predicted > 50% based on most recent pulmonary function test results 10 ...